AI-generated summary
The authors conducted a scoping review of 21 articles, published between 2011 and 2024, on strategies used to manage radiodermatitis in patients with head and neck cancer receiving radiotherapy. They report that several topical agents, including pharmacological therapies, phototherapy/photobiomodulation, and dressings, have been clinically tested. They conclude that the current research is insufficient in quantity and quality to support or refute widespread approval of any specific product.
- Studies included
- 21
- Who or what was studied
- Patients with head and neck cancer undergoing radiotherapy
- Limits stated in the abstract
- The authors state that the existing body of research is insufficient in both quantity and quality to conclusively support any specific product.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Photobiomodulation, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.